An FDA advisory committee has voted to back compounding access for two unproven peptides and rejected a third.

Elevation of interferon (IFN)α drives an immune endotype of Sjögren disease, according to a study published in the August issue of The Lancet Rheumatology. De ...

Patients with systemic lupus erythematosus have an increased risk of developing bronchiectasis, which is linked to higher mortality rates.

Patients with psoriatic arthritis exhibit distinct electrocardiographic abnormalities and cardiac arrhythmias.

Shortages in the rheumatologist workforce are projected across non-metropolitan areas, the south, and several US states through 2037.

Estimates indicate that the global morbidity gap is expanding, with individuals spending a greater proportion of life in poor health.

Adults with autoimmune rheumatic diseases commonly experience chronic overlapping pain conditions despite ongoing anti-inflammatory treatment.

Higher general physician knowledge is associated with a lower use of low-value medical services for older Medicare patients.

Echocardiography showed elevated myocardial dysfunction rates in patients with psoriasis, regardless of disease severity.

An external FDA advisory panel voted to allow specialized pharmacies to produce and sell four previously banned peptide treatments.

Higher body mass index in patients with knee osteoarthritis is associated with increased health care utilization and annual costs.

Central sensitization in patients with psoriatic arthritis is independently predicted by depression, poor sleep quality, and neuropathic pain.